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Association analysis in a Latin 
American population revealed 
ethnic differences in rheumatoid 
arthritis-associated Snps in 
caucasian and Asian populations
p. castro-Santos1,2, R. A. Verdugo  3,4, R. Alonso-Arias1,5, M. A. Gutiérrez6,7, J. Suazo8, 
J. C. Aguillón9, J. olloquequi1, C. pinochet10, A. Lucia11, L. A. Quiñones12,13,14 ✉ &  
R. Díaz-peña1,14 ✉
Large genome-wide association studies (GWAS) have increased our knowledge of the genetic 
risk factors of rheumatoid arthritis (RA). However, little is known about genetic susceptibility in 
populations with a large admixture of Amerindian ancestry. the aim of the present study was to test 
the generalizability of previously reported RA loci in a Latin American (LA) population with admixed 
ancestry. We selected 128 single nucleotide polymorphisms (SNPs) in linkage equilibrium, with high 
association to RA in multiple populations of non-Amerindian origin. Genotyping of 118 SNPs was 
performed in 313 RA patients/487 healthy control subjects by mid-density arrays of polymerase 
chain reaction (PCR). Some of the identified associations were validated in an additional cohort (250 
cases/290 controls). One marker, the SNP rs2451258, located upstream of T Cell Activation RhoGTPase 
Activating protein (TAGAP) gene, showed significant association with RA (p = 5 × 10−3), whereas 18 
markers exhibited suggestive associations (p < 0.05). Haplotype testing showed association of some 
groups of adjacent SNPs around the signal transducer and activator of transcription 4 (STAT4) gene 
(p = 9.82 × 10−3 to 2.04 × 10−3) with RA. Our major finding was little replication of previously reported 
genetic associations with RA. these results suggest that performing GWAS and admixture mapping in 
LA populations has the potential to reveal novel loci associated with RA. this in turn might help to gain 
insight into the ‘pathogenomics’ of this disease and to explore trans-population differences for RA in 
general.
Rheumatoid arthritis (RA) is an autoimmune inflammatory rheumatic disease that affects mainly synovial joints 
among many tissues and organs. It affects approximately 1% of the population worldwide1 and, although this 
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condition can develop at any age, RA affects women more frequently than men and is mainly diagnosed between 
the ages of 40–60 years. In Latin America (LA), differences towards women seem to be higher, whereas prevalence 
has been estimated between 0.2–0.5%2,3. In Chile, there are data showing that the overall prevalence of RA based 
on clinical examination is 0.46%4.
The etiology of RA is multifactorial and partially unknown because of the complex interactions between 
genetic and environmental factors. Approximately 50% of RA risk is thought to be genetic, and one-third of 
this risk is associated with the human leukocyte antigen (HLA) locus5, specifically HLA-DRB1 shared alleles 
(SE), which encode a common amino acid sequence6. Since 2007 about 101 RA risk loci have emerged from 
genome-wide association studies (GWAS) and subsequent GWAS meta-analyses7,8, mostly in individuals from 
European and/or Asian populations (Supplementary Table 1). In fact, none of the GWAS pertaining to RA has 
been performed in LA populations (Supplementary Table 1).
It is generally accepted that many common risk variants are shared between multiethnic populations, but 
allele frequencies of disease-associated single nucleotide polymorphisms (SNPs) vary significantly among ethnic 
groups due to genetic drift or selection9. Linkage between causal variants and tag SNPs included in genotyping 
microarrays might vary depending on population-specific pattern of recombination which in turn, is largely 
affected by population size, founder effects and admixture processes. In addition, populations with different his-
tories may carry distinct causal mutations even in similar loci. All of these factors can preclude generalization of 
genetic associations from one population to another, and suggest testing for locus- or haplotype-wise rather than 
SNP-wise generalization10.
López Herráez et al.11 examined susceptibility loci for RA in LA populations. In this study, a strong association 
with HLA region was observed, with three independent effects, probably due to the diverse origin of the patients 
(Argentina, Mexico, Chile, and Peru). Some of the RA associations previously reported in GWAS were also repli-
cated in the study by López Herráez and coworkers, but with moderate significant values (including protein tyros-
ine phosphatase, non-receptor type 22 (lymphoid) [PTPN22] and signal transducer and activator of transcription 
4 [STAT4] genes). However, in general, genetic association studies on RA have not been robustly replicated in LA 
populations. Therefore, the aim of the present study was to carry out a high-density SNP genotyping in candidate 
genes to test their association with susceptibility to RA in the Chilean population, in order to provide insight on 
the cross-ethnic generalizability of known European and Asian RA risk loci to LA populations.
Results
In the present study, five hundred and sixty-three (42.0%) of the included individuals suffered RA. Supplementary 
Table 2 shows the characteristics of the RA patients that were used for the analysis. The mean age was 48 and 58 
years for cohort 1 and 2, respectively, and 84.7% and 81.0% of the patients were women. The mean duration of the 
disease was 8 years. Anti-cyclic citrullinated peptide (CCP) antibodies were determined in a total of 218 patients 
being positive in 164 of them (75.23%), whereas rheumatoid factor (RF) was determined in 300 patients being 
positive in 264 (88.0%). The RA group did not differ from the control group with regard to any of the clinical 
parameters included in the study (data not shown).
The present findings do not show replicable association of individual SNPs with RA. Among 128 SNPs gen-
otyped, 118 passed all the quality filters, after excluding SNPs with a minor allele frequency <0.01 or missing-
ness > 0.1 and those that were not in Hardy-Weinberg equilibrium (HWE) (p < 0.001) (Supplementary Table 3). 
Only two markers (2%) showed significant associations (p ≤ 0.01): rs1635567 and rs2469434 (Table 1), of which 
none was confirmed in Cohort 2. When data from both cohorts were combined, rs2469434 was still significant 
whereas rs1635567 could not be tested because the assay failed in Cohort 2. However, the combined analysis 
revealed a new significant association for rs2451258 (combined p = 5 × 10−3; p = 0.09 after Bonferroni correction 
for multiple testing) (Table 1). Eighteen markers exhibited suggestive associations (p < 0.05), whereas the associ-
ations of the remainder of SNPs included in the study were not significant. The significantly-associated SNPs in 
peptidyl arginine deiminase, type IV (PADI4), Protein tyrosine phosphatase, non-receptor type 22 (PTPN22), sig-
nal transducer and activator of transcription 4 (STAT4), cytotoxic T-lymphocyte-associated protein 4 (CTLA4), 
tumor necrosis factor, alpha-induced protein 3 (TNFAIP3), and chemokine receptor 6 (CCR6 genes), identified in 
Caucasian and Asian populations, were not replicated in the Chilean population (Supplementary Fig. 1).
We next determined the correlation between odds ratio (OR) derived from our study and OR previously 
reported in GWAS from Caucasian and Asian population12 (Fig. 1). There was no correlation between data 
belonging to Caucasian population and our data (r = −0.041, p = 0.768), or between Asian populations and our 
data (r = 0.152, p = 0.302). In addition, the allele frequencies of RA-associated SNPs varied significantly among 
different ethnic groups (Fig. 2, Supplementary Fig. 2). The results of allele frequencies were concordant between 
our study (healthy controls vs. RA cases, p-value < 10−15 and r = 0.98) and ChileGenomico dataset (healthy con-
trols vs. ChileGenomico, p-value < 10−15 and r = 0.96). However, the allele frequency in European, East Asian, 
Aymara and Mapuche samples showed variability compared to our cohort (r ≤ 0.70).
The sliding window test revealed several SNP blocks that were associated with RA (Table 2). The p values for 
the strongest sliding window (ranging from p = 9.82 × 10−3 to 2.04 × 10−3) were associated with regions around 
STAT4 gene. In addition to the sliding window test, we also performed case-control studies based on linkage 
disequilibrium (LD) haplotype block reconstruction, not revealing associations between SNPs and RA. Detailed 
haplotype block information and the LD plot around the STAT4 gene are shown in Supplementary Fig. 3 . 
Discussion
The present study aimed to investigate the association of SNPs markers in candidate genes and RA in the Chilean 
population. Our main finding was a little replication of previously reported genetic associations with RA. Indeed, 
only 2% of know RA loci from GWAS studies in populations of European or Asian origin were significantly 
associated in our LA population, and just 11% showed a suggestive association. This was unexpected because 
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SNPs in well-known RA loci were tested, such as PADI4, PTPN22, STAT4, CTLA4, TNFAIP3, and CCR6 -none of 
which replicated. There are a number of reasons why previously GWAS-significant findings might not replicate in 
independent cohorts, as reviewed by Kraft et al.13. The small sample size of our study may be responsible for the 
CHR SNP POSITION Gene A1
Cohort 1 Cohort 2 Joint analysis
MAF
P
MAF
P
MAF
Combined P
RA 
Patients Controls
RA 
Patients Controls
RA 
Patients Controls
1 rs1635567a 17683041 PADI4 C 0.33 0.41 0.005
18 rs2469434 67544046 CD226 C 0.32 0.26 0.009 0.31 0.29 0.52 0.32 0.27 0.01
1 rs2477134 17633572 PADI4 G 0.37 0.31 0.016 0.38 0.35 0.34 0.37 0.32 0.03
7 rs3778753 a 128580042 IRF5 C 0.34 0.28 0.018
21 rs9979383 36715761 RUNX1 C 0.31 0.25 0.018 0.29 0.28 0.82 0.31 0.27 0.04
11 rs4409785 95311422 CEP57 C 0.16 0.12 0.029 0.14 0.13 0.63 0.15 0.12 0.04
2 rs3024903 191895607 STAT4 T 0.15 0.11 0.031 0.13 0.11 0.30 0.14 0.11 0.05
22 rs3218251 37545505 IL2RB A 0.18 0.14 0.037 0.18 0.13 0.03 0.18 0.14 0.02
6 rs2451258 159506600 TAGAP C 0.15 0.19 0.038 0.14 0.22 0.003 0.15 0.20 0.005
20 rs4239702 a 44749251 CD40 T 0.22 0.18 0.044
8 rs998731 81095395 TDP52 C 0.36 0.31 0.051 0.33 0.34 0.88 0.36 0.32 0.04
10 rs2275806 8095340 GATA3 A 0.38 0.43 0.052 0.38 0.44 0.08 0.38 0.43 0.02
1 rs2843401 2528133 MMEL1 T 0.41 0.46 0.058 0.40 0.43 0.28 0.40 0.45 0.02
4 rs2664035 48220839 TEC A 0.39 0.44 0.064 0.39 0.38 0.70 0.39 0.42 0.16
2 rs10175798 30449594 LBH G 0.33 0.37 0.068 0.34 0.35 0.88 0.33 0.37 0.11
11 rs73013527 128496952 ETS1 T 0.36 0.41 0.073 0.36 0.39 0.43 0.36 0.41 0.04
2 rs11889341 191943742 STAT4 T 0.42 0.38 0.074 0.43 0.38 0.09 0.43 0.38 0.02
14 rs1950897 68760141 RAD51B G 0.21 0.25 0.078 0.20 0.23 0.29 0.20 0.24 0.05
16 rs4780401 11839326 TNXNDC11 T 0.40 0.35 0.079 0.39 0.34 0.07 0.39 0.35 0.05
2 rs11571302 204742934 CTLA4 G 0.52 0.47 0.088 0.52 0.46 0.07 0.47 0.52 0.02
20 rs6032662 44734310 CD40 C 0.21 0.18 0.091 0.20 0.20 0.92 0.20 0.18 0.14
1 rs2228145 154426970 IL6R A 0.42 0.38 0.093 0.43 0.40 0.32 0.44 0.39 0.02
17 rs12936409 38043649 IKZF3 A 0.46 0.42 0.1 0.45 0.41 0.27 0.46 0.42 0.07
Table 1. Association analysis of the replicated SNPs as single markers in cohort 1 and cohort 2 and the joint 
analysis (only SNPs with P ≤ 0.1 are shown). CHR = chromosome; SNP = single-nucleotide polymorphism; 
A1 = minor allele nucleotide; RA = rheumatoid arthritis; and MAF = minor allele frequency. aFailed in the 
replication phase (genotyping of the cohort 2).
Gene Markers Pvalue
STAT4
rs3024903|rs3024896|rs4853540|rs16833220 3,94 × 10−3
rs11889341|rs12990918|rs6434435|rs10931480 9,82 × 10−3
rs3024903|rs3024896|rs4853540|rs16833220|rs11893432 6,26 × 10−3
rs3024903|rs3024896|rs4853540|rs16833220|rs11893432|rs3024861 9,59 × 10−3
rs12990918|rs6434435|rs10931480|rs10931481|rs7574865|rs6752770|rs1551440|rs11685878|rs4853546 8,48 × 10-3
rs12990918|rs6434435|rs10931480|rs10931481|rs7574865|rs6752770|rs1551440|rs11685878|rs4853546|
rs7574070 3,34 × 10
−3
rs12990918|rs6434435|rs10931480|rs10931481|rs7574865|rs6752770|rs1551440|rs11685878|rs4853546|rs7574
070|rs12327969 2,04 × 10
−3
rs2459611|rs11889341|rs12990918|rs6434435|rs10931480|rs10931481|rs7574865|rs6752770|rs1551440|rs1168
5878|rs4853546|rs7574070 9,11 × 10
−3
rs3024896|rs4853540|rs16833220|rs11893432|rs3024861|rs1517352|rs13426947|rs2459611|rs11889341|rs1299
0918|rs6434435|rs10931480|rs10931481|rs7574865|rs6752770 7,79 × 10
−3
rs3024903|rs3024896|rs4853540|rs16833220|rs11893432|rs3024861|rs1517352|rs13426947|rs2459611|rs11889
341|rs12990918|rs6434435|rs10931480|rs10931481|rs7574865|rs6752770|rs1551440 4,32 × 10
−3
rs4853540|rs16833220|rs11893432|rs3024861|rs1517352|rs13426947|rs2459611|rs11889341|rs12990918|rs643
4435|rs10931480|rs10931481|rs7574865|rs6752770|rs1551440|rs11685878|rs4853546|rs7574070 5,77 × 10
−3
rs4853540|rs16833220|rs11893432|rs3024861|rs1517352|rs13426947|rs2459611|rs11889341|rs12990918|`rs643
4435|rs10931480|rs10931481|rs7574865|rs6752770|rs1551440|rs11685878|rs4853546|rs7574070|rs12327969 5,88 × 10
−3
T a b le 2. Association analyses of sliding windows of 4–19 single-nucleotide polymorphisms within STAT4 (only 
p values < 10−2 are shown), using the chi-square test in Plink software (15).
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modest number of SNPs that showed associations validated in our participants. Sample sizes larger than the one 
used here are needed to reach high confidence levels and strong statistical power. In this regard, the low preva-
lence of the disease restricted the number of patients that we were able to recruit for our study. A long-term effort 
to progressively collect numerous patients’ samples from biobanks might allow to perform more powered genetic 
studies and to test for generalizability of genetic associations. Similarly, we believe that the small sample size is 
a main reason for the lack of differences we found between endophenotypes. Our study did not reach statistical 
power for one-third of the SNPs analyzed, which might provide a possible explanation, at least in part, for the 
lack of replication of the results in the Chilean population. However, if lack of power was the only explanation, it 
is expected that, overall, the OR values would follow the same trend in Chilean patients as in other populations. 
However, ORs in Chile show absolutely no correlation with estimates from studies with Europeans and only a 
very week positive association with Asians (Fig. 1). This suggests that genetic divergence between populations at 
these loci may be one of the reasons of the lack generalization of SNP associations.
Differences in LD patterns between populations may preclude replication of association, which can be caused 
by multiple factors such as different demographic history including population-specific bottlenecks, genetic drift, 
selection, and recent admixture, among others14. Large diversity in LD among populations from different conti-
nents, including the Americas, is well documented15. Furthermore, RA is a trait associated with loci responsible 
for the immune response, which in turn is highly associated with local adaptations and disease resistance. In 
support for the above interpretation of our results, although we did not find any significant SNP-wise association 
of STAT4 with RA, we did find association for this locus when testing haplotypes instead of genotypes. Using the 
sliding window test revealed several haplotype associations with RA, suggesting the possible existence of untested 
(potentially functional) genetic variation within STAT4 in the Chilean population, a result that other studies with 
different populations might had failed to detect or might had not shown the strongest signal. Further investi-
gations are required to confirm these findings. The strongest association was observed for the SNP rs2451258 
located upstream of the T-cell activation RhoGTPase activating protein (TAGAP) gene, although the p-value was 
>0.05 after Bonferroni correction for multiple testing. This variant is not within any protein-coding sequence or 
disrupted a non-coding functional motif, but TAGAP would be a promising biological candidate gene12. TAGAP 
gene encodes a member of the Rho GTPase-activator protein superfamily, but little is known about their role in 
the immune system. Additional investigations, with higher of variants in the region are required to confirm this 
hypothesis.
Polygenic risk scores could be the next great stride in genomic medicine, which is generating a considerable 
debate regarding their use in complex phenotypes16. Recently, Khera et al. proposed that it is time to contemplate 
the incorporation of polygenic risk prediction in clinical care17, projecting these scores across a wide variety of 
diseases. The risk scores have been generated and tested mainly in individuals of primarily European ancestry. 
In the present study, significant values of the previously detected SNP-wise associations were moderate and a 
better generalizability was found when testing association between phenotype and haplotypes rather than SNPs. 
Moreover, allele frequency vary between populations of different ancestries. These results suggest the existence 
of genomic patterns in Chilean, and probably other LA populations, that differentiate them from Europeans with 
regard to loci that are relevant for RA. This can be caused by different demographic histories (e.g., past population 
bottlenecks and migration events, or ancestries18–20). Haplotype-based associations may capture the interact-
ing effects among two or more potential causal variants within certain genomic region, which single-variants 
Figure 1. Correlation between log(odds ratio) from data published in GWA studies carried out in Caucasian an 
Asian population versus log(odds ratio) reported in this study (7). OR = odds ratio; GWA = genome association 
analysis. The respective regression lines with the Pearson correlation’s r-values are indicated.
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approach cannot detect. Therefore, haplotype-based approaches show a greater power to map susceptibility genes 
in complex traits than single-marker methods21,22. These results support the need for GWAS in LA populations, 
including Chileans, to discover potentially novel loci accounting for genetic risk for RA, to investigate the con-
tribution of genetic ancestry, and to improve performance of polygenic prediction models in these populations.
Methods
Study participants. A total of 1.340 individuals were studied as two distinct cohorts. Cohort 1 comprised 
313 patients with RA and 487 healthy control subjects; cohort 2 included 250 RA patients and 290 healthy con-
trols. The patients with RA were diagnosed following the 2010 American College of Rheumatology/European 
League Against Rheumatism (ACR/EULAR) classification criteria23. The study was approved by the Ethical 
Committee of the “Servicio de Salud del Maule” (registration number 04/2014), Chile; and all individuals gave 
their written informed consent prior to enrolling in the study. All methods were performed in accordance with 
the relevant guidelines and regulations.
Snp selection and genotyping. A total of 128 SNPs from 73 genes were chosen for genotyping from 
previous GWAS in populations of diverse ethnic background7,11. Supplementary Table 3 shows SNPs elected for 
our analysis. Some of them were selected as haplotype-tag-SNPs (ht-SNPs) based on LD patterns located within 
our candidate genes (PADI4, PTPN22, STAT4, CTLA4, TNFAIP3 and CCR6) and using the HapMap dataset24. 
Haplotype tagging (Ht)-SNPs were selected using the Tagger tool of Haploview25, under the following criteria: 
minor allele frequency ≥0.01 and r2 > 0.8, and based on the HapMap populations (CEU, CEU + TSI and MEX). 
Some of the identified associations were validated by genotyping 23 SNPs in the cohort 2. The SNPs were geno-
typed using the OpenArray®™ TaqMan platform (Applied Biosystems Inc.) in the test (Cohort 1) and replica-
tion (Cohort 2) samples. The genotyping assays were performed at the Pfizer-University of Granada-Junta de 
Andalucía Centre for Genomics and Oncological Research (GENYO) (Cohort 1), Granada, Spain; and at the 
Centro Nacional de Genotipado (Cohort 2), at the Santiago de Compostela node, Spain.
Genotyping data from reference populations. In order to assess ethnic differences in allelic frequencies 
for the SNPs evaluated in this work, we obtained genotypes for 108 AFR, 99 EUR, and 103 EAS unrelated indi-
viduals from the 1000 Genomes Project Phase 3 dataset (http://www.1000genomes.org). For Amerindian ances-
try, we obtained genotypes for 85 individuals of Aymara ancestry (AYM), 54 individuals of Mapuche ancestry 
(MAP), and 348 of Chilean ancestry (CLG) from the ChileGenomico Project (http://chilegenomico.med.uchile.
cl). AYM, MAP, and CLG individuals were genotyped using the Axion LAT1 Array (Affymetrix, Inc., Santa Clara, 
California, U.S.) and imputed using the 1000 Genomes Project phase 326.
Figure 2. Correlation matrix between allele frequencies of the SNPs analyzed in different populations. 
MAF = minor allele frequency; AF = allele frequency; AFR = African; EUR = European; EAS = East Asian; 
AYM = Aymara; MAP = Mapuche; CHG = ChileGenomico.
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Statistical analysis. Power calculations were done with the GAS Power Calculator tool (http://csg.sph.
umich.edu) assuming a multiplicative model, with OR = 1.5, a significance level of 0.05 and an RA prevalence of 
0.5%. Only SNPs that met the quality criteria of a minor allele frequency (MAF) > 0.01, missingness < 0.1, and/
or HWE P > 0.001 were considered for inclusion in the association analyses (Supplementary Table 3). Allele 
frequencies were compared between RA patients and control populations by chi-square test, and OR with 95% 
confidence intervals (95% CI) were calculated using PLINK software (v1.07)27. Haplotype analysis was performed 
using Haploview software (v4.2)25. In addition, haplotypes based on 1-bp sliding windows of 2 to 21 SNPs each 
were also constructed. Association analyses were done with the chi-square test using PLINK. Pearson’s corre-
lations and linear regression were used to evaluate differences between genetic background. The LocusZoom 
web-based resource was used to generate plots of association results by genomic region28.
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